260 related articles for article (PubMed ID: 31445164)
41. Defective glucocorticoid hormone receptor signaling leads to increased stress and anxiety in a mouse model of Angelman syndrome.
Godavarthi SK; Dey P; Maheshwari M; Jana NR
Hum Mol Genet; 2012 Apr; 21(8):1824-34. PubMed ID: 22215440
[TBL] [Abstract][Full Text] [Related]
42. Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology.
Pandya NJ; Wang C; Costa V; Lopatta P; Meier S; Zampeta FI; Punt AM; Mientjes E; Grossen P; Distler T; Tzouros M; Martà Y; Banfai B; Patsch C; Rasmussen S; Hoener M; Berrera M; Kremer T; Dunkley T; Ebeling M; Distel B; Elgersma Y; Jagasia R
Cell Rep Med; 2021 Aug; 2(8):100360. PubMed ID: 34467244
[TBL] [Abstract][Full Text] [Related]
43. An Autism-Linked Mutation Disables Phosphorylation Control of UBE3A.
Yi JJ; Berrios J; Newbern JM; Snider WD; Philpot BD; Hahn KM; Zylka MJ
Cell; 2015 Aug; 162(4):795-807. PubMed ID: 26255772
[TBL] [Abstract][Full Text] [Related]
44. Conserved UBE3A subcellular distribution between human and mice is facilitated by non-homologous isoforms.
Zampeta FI; Sonzogni M; Niggl E; Lendemeijer B; Smeenk H; de Vrij FMS; Kushner SA; Distel B; Elgersma Y
Hum Mol Genet; 2020 Nov; 29(18):3032-3043. PubMed ID: 32879944
[TBL] [Abstract][Full Text] [Related]
45. Angelman syndrome protein UBE3A interacts with primary microcephaly protein ASPM, localizes to centrosomes and regulates chromosome segregation.
Singhmar P; Kumar A
PLoS One; 2011; 6(5):e20397. PubMed ID: 21633703
[TBL] [Abstract][Full Text] [Related]
46. Ube3a imprinting impairs circadian robustness in Angelman syndrome models.
Shi SQ; Bichell TJ; Ihrie RA; Johnson CH
Curr Biol; 2015 Mar; 25(5):537-45. PubMed ID: 25660546
[TBL] [Abstract][Full Text] [Related]
47. UBE3A-mediated PTPA ubiquitination and degradation regulate PP2A activity and dendritic spine morphology.
Wang J; Lou SS; Wang T; Wu RJ; Li G; Zhao M; Lu B; Li YY; Zhang J; Cheng X; Shen Y; Wang X; Zhu ZC; Li MJ; Takumi T; Yang H; Yu X; Liao L; Xiong ZQ
Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12500-12505. PubMed ID: 31160454
[TBL] [Abstract][Full Text] [Related]
48. Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome.
Lee D; Chen W; Kaku HN; Zhuo X; Chao ES; Soriano A; Kuncheria A; Flores S; Kim JH; Rivera A; Rigo F; Jafar-Nejad P; Beaudet AL; Caudill MS; Xue M
Elife; 2023 Jan; 12():. PubMed ID: 36594817
[No Abstract] [Full Text] [Related]
49. Potential therapeutic approaches for Angelman syndrome.
Bi X; Sun J; Ji AX; Baudry M
Expert Opin Ther Targets; 2016; 20(5):601-13. PubMed ID: 26558806
[TBL] [Abstract][Full Text] [Related]
50. Impaired hippocampal plasticity and altered neurogenesis in adult Ube3a maternal deficient mouse model for Angelman syndrome.
Mardirossian S; Rampon C; Salvert D; Fort P; Sarda N
Exp Neurol; 2009 Dec; 220(2):341-8. PubMed ID: 19782683
[TBL] [Abstract][Full Text] [Related]
51. Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome Mouse Brain.
Bailus BJ; Pyles B; McAlister MM; O'Geen H; Lockwood SH; Adams AN; Nguyen JT; Yu A; Berman RF; Segal DJ
Mol Ther; 2016 Mar; 24(3):548-55. PubMed ID: 26727042
[TBL] [Abstract][Full Text] [Related]
52. Transcriptional reprogramming restores UBE3A brain-wide and rescues behavioral phenotypes in an Angelman syndrome mouse model.
O'Geen H; Beitnere U; Garcia MS; Adhikari A; Cameron DL; Fenton TA; Copping NA; Deng P; Lock S; Halmai JANM; Villegas IJ; Liu J; Wang D; Fink KD; Silverman JL; Segal DJ
Mol Ther; 2023 Apr; 31(4):1088-1105. PubMed ID: 36641623
[TBL] [Abstract][Full Text] [Related]
53. Mutation Update for UBE3A variants in Angelman syndrome.
Sadikovic B; Fernandes P; Zhang VW; Ward PA; Miloslavskaya I; Rhead W; Rosenbaum R; Gin R; Roa B; Fang P
Hum Mutat; 2014 Dec; 35(12):1407-17. PubMed ID: 25212744
[TBL] [Abstract][Full Text] [Related]
54. Activity-dependent changes in MAPK activation in the Angelman Syndrome mouse model.
Filonova I; Trotter JH; Banko JL; Weeber EJ
Learn Mem; 2014 Jan; 21(2):98-104. PubMed ID: 24434871
[TBL] [Abstract][Full Text] [Related]
55. Maternal disruption of Ube3a leads to increased expression of Ube3a-ATS in trans.
Landers M; Calciano MA; Colosi D; Glatt-Deeley H; Wagstaff J; Lalande M
Nucleic Acids Res; 2005; 33(13):3976-84. PubMed ID: 16027444
[TBL] [Abstract][Full Text] [Related]
56. Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a.
Yamasaki K; Joh K; Ohta T; Masuzaki H; Ishimaru T; Mukai T; Niikawa N; Ogawa M; Wagstaff J; Kishino T
Hum Mol Genet; 2003 Apr; 12(8):837-47. PubMed ID: 12668607
[TBL] [Abstract][Full Text] [Related]
57. A cross-species spatiotemporal proteomic analysis identifies UBE3A-dependent signaling pathways and targets.
Pandya NJ; Meier S; Tyanova S; Terrigno M; Wang C; Punt AM; Mientjes EJ; Vautheny A; Distel B; Kremer T; Elgersma Y; Jagasia R
Mol Psychiatry; 2022 May; 27(5):2590-2601. PubMed ID: 35264729
[TBL] [Abstract][Full Text] [Related]
58. Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome.
Colas D; Wagstaff J; Fort P; Salvert D; Sarda N
Neurobiol Dis; 2005 Nov; 20(2):471-8. PubMed ID: 15921919
[TBL] [Abstract][Full Text] [Related]
59. Angelman Syndrome: From Mouse Models to Therapy.
Rotaru DC; Mientjes EJ; Elgersma Y
Neuroscience; 2020 Oct; 445():172-189. PubMed ID: 32088294
[TBL] [Abstract][Full Text] [Related]
60. UBE3A-mediated p18/LAMTOR1 ubiquitination and degradation regulate mTORC1 activity and synaptic plasticity.
Sun J; Liu Y; Jia Y; Hao X; Lin WJ; Tran J; Lynch G; Baudry M; Bi X
Elife; 2018 Jul; 7():. PubMed ID: 30020076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
